EN 简
PNAS
Jan 21, 2020
LRCH1 deficiency enhances LAT signalosome formation and CD8+ T cell responses against tumors and pathogens
Chang Liu, Xiaoyan Xu, Lei Han, Xiaopeng Wan, Lingming Zheng, Chunyang Li, Zhaohui Liao, Jun Xiao, Ruiyue Zhong, Xin Zheng, Qiong Wang, Zonghai Li, Hualan Chene, Bin Wei, Hongyan Wang
Frontiers in Oncology
Dec 19, 2019
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR T cells
Hong Luo, Xiuqi Wu, Ruixin Sun, Jingwen Su, Yi Wang, Yiwei Dong, Bizhi Shi, Yansha Sun, Hua Jiang, Zonghai Li
Signal Transduction and Targeted Therapy
Sep 20, 2019
Genetically engineered T cells for cancer immunotherapy
Dan Li, Xue Li, Wei-Lin Zhou, Yong Huang, Xiao Liang, Lin Jiang, Xiao Yang, Jie Sun, Zonghai Li, Wei-Dong Han, Wei Wang
The Journal of Immunology
Jul 01, 2019
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
Ying Liu, Shengmeng Di, Bizhi Shi, Honghong Zhang, Yi Wang, Xiuqi Wu, Hong Luo, Huamao Wang, Zonghai Li, Hua Jiang
Molecular Therapy
Apr 29, 2019
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
Xiuqi Wu, Hong Luo, Bizhi Shi, Shengmeng Di, Ruixin Sun, Jingwen Su, Ying Liu, Hua Li, Hua Jiang, Zonghai Li
Frontiers in Oncology
Apr 17, 2019
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR T cells
Shengmeng Di , Min Zhou, Zeyan Pan, Ruixin Sun, Muhua Chen, Hua Jiang, Bizhi Shi , Hong Luo, Zonghai Li
Cancer Immunology Research
Nov 01, 2018
Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell
Hua Jiang, Huiping Gao, Juan Kong, Bo Song, Peng Wang, Bizhi Shi, Huamao Wang, Zonghai Li
Frontiers in Pharmacology
Oct 01, 2018
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Xingliang Guo, Hua Jiang, Bizhi Shi, Min Zhou, Honghong Zhang, Zhimin Shi, Guoxiu Du, Hong Luo, Xiuqi Wu, Yi Wang, Ruixin Sun, Zonghai Li
JNCI
Sep 06, 2018
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
Hua Jiang, Zhimin Shi, PengWang, Cong Wang, Linlin Yang, Guoxiu Du, Honghong Zhang, Bizhi Shi, Jie Jia, Qixiang Li, Huamao Wang, Zonghai Li
Cancer Immunology, Immunotherapy
Aug 04, 2018
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
Zeyan Pan, Shengmeng Di, Bizhi Shi, Hua Jiang, Zhimin Shi, Ying Liu, Yi Wang, Hong Luo, Min Yu, Xiuqi Wu, Zonghai Li